1. Home
  2. SYRE vs AGRO Comparison

SYRE vs AGRO Comparison

Compare SYRE & AGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • AGRO
  • Stock Information
  • Founded
  • SYRE 2013
  • AGRO 2002
  • Country
  • SYRE United States
  • AGRO Luxembourg
  • Employees
  • SYRE N/A
  • AGRO N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • AGRO Farming/Seeds/Milling
  • Sector
  • SYRE Health Care
  • AGRO Consumer Staples
  • Exchange
  • SYRE Nasdaq
  • AGRO Nasdaq
  • Market Cap
  • SYRE 1.1B
  • AGRO 919.9M
  • IPO Year
  • SYRE 2016
  • AGRO 2011
  • Fundamental
  • Price
  • SYRE $14.82
  • AGRO $8.22
  • Analyst Decision
  • SYRE Strong Buy
  • AGRO Hold
  • Analyst Count
  • SYRE 5
  • AGRO 4
  • Target Price
  • SYRE $61.25
  • AGRO $11.13
  • AVG Volume (30 Days)
  • SYRE 485.5K
  • AGRO 624.4K
  • Earning Date
  • SYRE 11-06-2025
  • AGRO 11-12-2025
  • Dividend Yield
  • SYRE N/A
  • AGRO 4.16%
  • EPS Growth
  • SYRE N/A
  • AGRO N/A
  • EPS
  • SYRE N/A
  • AGRO 0.35
  • Revenue
  • SYRE N/A
  • AGRO $1,553,301,000.00
  • Revenue This Year
  • SYRE N/A
  • AGRO N/A
  • Revenue Next Year
  • SYRE N/A
  • AGRO $1.19
  • P/E Ratio
  • SYRE N/A
  • AGRO $23.18
  • Revenue Growth
  • SYRE N/A
  • AGRO 17.41
  • 52 Week Low
  • SYRE $10.91
  • AGRO $7.90
  • 52 Week High
  • SYRE $40.26
  • AGRO $12.08
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 34.55
  • AGRO 41.92
  • Support Level
  • SYRE $15.80
  • AGRO $7.90
  • Resistance Level
  • SYRE $17.58
  • AGRO $8.27
  • Average True Range (ATR)
  • SYRE 0.74
  • AGRO 0.18
  • MACD
  • SYRE -0.24
  • AGRO 0.01
  • Stochastic Oscillator
  • SYRE 5.32
  • AGRO 46.38

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About AGRO Adecoagro S.A.

Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.

Share on Social Networks: